This Solicitation opportunity from Hawaii was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

FENTANYL DETECTION, EARLY INTERVENTION - 12 PANEL DRUG TEST KIT

Closed

B26002727State & Local

Submission Closed06/04/2026, 02:30:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210

New

DIBBS

PLASMA-LYTE A INJECThe contract involves the procurement of PLASMA-LYTE A INJEC, identified by NSN 6505-01-708-9039, with a total quantity of three units requested under purchase request number 7017120906. The solicitation, designated SPE2DP-26-T-3802, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. The response deadline for the solicitation is June 22, 2026, indicating a brief window for submissions. This contract is categorized as a solicitation with no specified type of set-aside or applicable NAICS code, and the performance location details are not provided. The contracting agency is a federal entity focusing on defense logistics, ensuring the procurement supports government operations. Relevant contract information and updates are accessible via the Defense Logistics Agency's procurement platform.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by the National Stock Number 6505-01-718-3484. The request involves a quantity of five units under purchase request number 7013890090. This solicitation, numbered SPE2DP-26-T-3808, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The procurement is managed by the Defense Logistics Agency, a federal organization within the Department of Defense, and is intended for performance within the United States, although specific locations are not specified. This contract solicitation falls under federal acquisition and does not indicate any set-aside type or NAICS code, implying it may be open to all qualified bidders. The relevant information is accessible through the Defense Logistics Agency’s online portal, where potential vendors can review and respond to the request. Points of contact are not provided in the available data, indicating that interested parties may need to use the online platform for further inquiries.

Defense Logistics Agency

POSTED

DEADLINE

REHYDRATION SALTS FThe contract pertains to the procurement of rehydration salts, specifically identified by the NSN/Part Number 6505-01-731-2277, with a total quantity of 2 units requested under purchase request number 7015714540. The solicitation, titled "REHYRATION SALTS F," was issued by the Defense Logistics Agency, a component of the Department of Defense, on June 15, 2026. Interested parties were required to submit their responses by the deadline of June 22, 2026. This federal solicitation lacks set-aside designations and NAICS code details, indicating it was open to all qualified bidders. The place of performance details were unspecified, suggesting flexibility or further clarification in subsequent communications. The contract focuses on meeting the agency's need for these medical supplies, likely for use in rehydration treatment scenarios, aligning with the Department of Defense's logistical and operational requirements.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by NSN/Part Number 6505-01-718-3478, with a purchase request quantity of five units. This solicitation, numbered SPE2DP-26-T-3803, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The contracting agency responsible for this procurement is the Defense Logistics Agency under the Department of Defense. This contract is a federal solicitation with no set-aside type indicated, and no specific NAICS code was assigned. While the precise location for the place of performance and the office address details are not provided, the procurement is handled within the United States. The contract is publicly available for review on the Defense Logistics Agency’s electronic bidding system, allowing eligible vendors to respond within the designated timeframe.

Defense Logistics Agency

POSTED

DEADLINE

PSYLLIUM HYDROPHILIThe contract pertains to the procurement of Psyllium Hydrophili, identified by the NSN/Part Number 6505-01-719-3181, with a purchase request for a quantity of three units. The solicitation, numbered SPE2DP-26-T-3801, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. It is a federal solicitation, with a response deadline set for June 22, 2026. The contract does not specify any set-aside type or NAICS code, and the exact location details for the office or place of performance are not provided. This solicitation is intended to acquire the specified product through a formal bidding process managed by a federal defense agency. Interested parties are able to access the solicitation and submit their responses through the Defense Logistics Agency’s bidding platform. The contract focuses on ensuring timely procurement within the established deadlines and under federal regulations relevant to government acquisitions.

Defense Logistics Agency

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

The Hawaii Paroling Authority is seeking competitive sealed bids from qualified vendors to establish a statewide price list contract for integrated urine-based 12-panel drug testing kits with fentanyl detection capabilities. These kits are intended to support various supervision and treatment efforts, including clinical monitoring, treatment compliance, abstinence verification, early intervention, and relapse detection for individuals under HPA supervision. The drug testing kits must detect a range of controlled substances — THC, Buprenorphine, Benzodiazepines, Methadone, Amphetamines, Oxycodone, Opiates, MDMA/Ecstasy, Cocaine, Methamphetamine, Alcohol (EtG), and Fentanyl — with high analytical sensitivity to identify low concentrations, meeting clinical monitoring standards. The estimated annual consumption is approximately 6,000 kits, which will be delivered on an as-needed basis to HPA offices across Oahu, Hawaiʻi Island, Maui, and Kauaʻi. The contract is set to begin on July 1, 2026, running through June 30, 2027, with options to extend for three additional one-year periods, contingent on contractor performance, operational need, and funding availability. All submissions and correspondence related to this solicitation must be conducted electronically through the Hawaii electronic procurement system HIePRO, with a response deadline of June 4, 2026. Primary contact for this solicitation is Marc Yamamoto from the Department of Corrections and Rehabilitation, Hawaii.

General Info

Hawaii seeks vendors for statewide urine drug test kits contract, starting July 2026, with extensions.

Agency

Hawaii → Department of Corrections and Rehabilitation

Contract Value

$299

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers View NAICS

Place of Performance

HI, US

Set-Aside

NONE

Awardee

Biotech ScreeningView Profile

Award Issued Date

06/09/2026, 12:00:00 AM UTC

Documents

(3)

HPA Competitive Seal Bid IFB No 26002727 for Fentanyl Detection Drug Test Kits

PDF•ifb

HPA IFB 26002727 Fentanyl Detection 12-Panel Drug Kits

PDF•ifb

AG-008 103D General Conditions (1.10.23)

PDF•general-conditions

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 11

Solicitation

Response DeadlineJun 4

Deadline has passed

Submission Closed

06/04/2026, 02:30:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyHawaii → Department of Corrections and Rehabilitation

Contacts2 people available

OfficeHI, US

Organization / Agency

Hawaii → Department of Corrections and Rehabilitation

Office AddressHI, US

Contacts

Marc Yamamoto

contact@example.gov

+1 (555) 000-0000

Earl Everett

Full Description

The Hawaii Paroling Authority (HPA) is requesting competitive sealed bids from qualified vendors to establish a Statewide price list contract for the purchase and delivery of integrated urine-based 12-panel drug testing kits with fentanyl detection capabilities. The testing kits will support HPA’s Statewide supervision, clinical monitoring, treatment compliance, abstinence verification, early intervention, and relapse detection efforts for supervised individuals under HPA jurisdiction. Proposed products shall meet clinical monitoring standards and demonstrate high analytical sensitivity for the detection of low concentrations of controlled substances, including fentanyl. The solicitation requires integrated 12-panel drug testing kits capable of detecting the following analytes: THC, Buprenorphine, Benzodiazepines, Methadone, Amphetamines, Oxycodone, Opiates, MDMA/Ecstasy, Cocaine, Methamphetamine, Alcohol (EtG), and Fentanyl. Estimated annual usage is approximately 6,000 kits Statewide. Deliveries will be ordered on an as-needed basis and distributed to HPA offices located on Oahu, Hawaiʻi Island, Maui, and Kauaʻi. The resulting contract term shall be from July 1, 2026 through June 30, 2027, with the option to extend for up to three (3) additional twelve (12)-month periods, subject to satisfactory contractor performance, continued operational need, and availability of funds. All proposals, questions, and solicitation communications shall be submitted electronically through HIePRO in accordance with the solicitation requirements and deadlines.